Time Trends in Physician Visits for Gastroesophageal Reflux Disease Before and After the Rx-to-OTC Switch of Proton Pump Inhibitors.
Divisions of Respiratory and Critical Care Physiology and Medicine, Los Angeles Biomed Research Institute at Harbor-University of California at Los Angeles Medical Center, Torrance, CA, USA.
Dong W
DW
Chang
Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Jonathan
J
Grotts
Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Chi-Hong
CH
Tseng
Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Eric P
EP
Brass
D000553:Ambulatory Care / Q000379:methods / Q000639:trends*; D057915:Drug Substitution / Q000379:methods / Q000639:trends*; D005260:Female; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000188:drug therapy*; D006306:Health Surveys / Q000379:methods / Q000639:trends; D006801:Humans; D008297:Male; D008875:Middle Aged; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D009819:Office Visits / Q000639:trends*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D013997:Time Factors
D004366:Nonprescription Drugs; D054328:Proton Pump Inhibitors
epidemiology; gastrointestinal; internal medicine; pharmacoepidemiology; regulatory/scientific affairs